Login / Signup

Cerebellar pathology and disability worsening in relapsing-remitting multiple sclerosis: A retrospective analysis from the CombiRx trial.

Maria PetraccaGary CutterSirio CocozzaLeorah FreemanJohn KangarluMonica MargoniMatteo MoroStephen KriegerMohamed Mounir El MendiliAmgad DrobyJerry S WolinskyFred LublinMatilde Inglese
Published in: European journal of neurology (2021)
Among the explored outcomes, single time-point evaluation of cerebellar damage only allows the prediction of manual dexterity worsening. In clinical studies the selection of imaging biomarkers should be informed by the outcome of interest.
Keyphrases
  • multiple sclerosis
  • high resolution
  • white matter
  • study protocol
  • clinical trial
  • oxidative stress
  • phase iii
  • phase ii
  • randomized controlled trial
  • mass spectrometry
  • systemic lupus erythematosus
  • weight loss